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Short- and Long-Wave UV Light (UVB and UVA)
Induce Similar Mutations in Human Skin Cells
Ulrike P. Kappes1, Dan Luo1,3, Marisa Potter1, Karl Schulmeister2 and Thomas M. Ru¨nger1
While the mutagenic and carcinogenic properties of longwave UV light (UVA) are well established, mechanisms
of UVA mutagenesis remain a matter of debate. To elucidate the mechanisms of mutation formation with UVA in
human skin, we determined the spectra of UVA- and UVB-induced mutations in primary human fibroblasts. As
with UVB, we found the majority of mutations to be C-to-T transitions also with UVA. For both UVA and UVB,
these transitions were found within runs of pyrimidines, at identical hotspots, and with the same predilection
for the nontranscribed strand. They also included CC-to-TT tandem mutations. Therefore, these mutations point
to a major role of pyrimidine dimers not only in UVB but also in UVA mutagenesis. While some differences were
noted, the similarity between the spectra of UVA- and UVB-induced mutations further supports similar
mechanisms of mutation formation. A non-dimer type of DNA damage does not appear to play a major role in
either UVA or UVB mutagenesis. Therefore, the previously reported increasing mutagenicity per dimer with
increasing wavelengths cannot be due to non-dimer DNA damage. Differences in the cellular response to UVA
and UVB, such as the less prominent activation of p53 by UVA, might determine a different mutagenic outcome
of UVA- and UVB-induced dimers.
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INTRODUCTION
The mutagenic and carcinogenic properties of sunlight have
been attributed to the short-wavelength range (UVB,
290–320 nm) of the solar UV spectrum. Despite being well
established that UVA (320–400 nm) can also damage DNA
and that it has mutagenic and carcinogenic properties (Stary
and Sarasin, 2000), the relevance of these effects for solar
mutagenesis and skin carcinogenesis remains unproven.
There are several indications that UVA in particular might
play an important role in the pathogenesis of cutaneous
malignant melanoma, the deadliest type of skin cancer (Moan
et al., 1999; Ru¨nger, 1999; Wang et al., 2001). However, this
has recently been questioned, as only UVB, but not UVA,
induced melanoma in a transgenic mouse model (De Fabo
et al., 2004).
The exact mechanisms of UVA mutagenesis are still a
matter of debate (Douki et al., 1999). It is generally accepted
that pyrimidine dimers, namely cyclobutane pyrimidine di-
mers (CPDs) and pyrimidine (6,4) pyrimidone photoproducts,
are the major mutagenic lesions for UVB. Several lines of
evidence indicate that pyrimidine dimers are not the only or
major mutagenic lesions with UVA: Enninga et al. (1986)
reported that mutagenicity per dimer increased with increas-
ing wavelength, in particular within the UVA range. Further
evidences include differences in the spectrum of UVA- and
UVB-induced mutations (Drobetsky et al., 1995; Robert et al.,
1996; Besaratinia et al., 2004), a lower incidence of p53
mutations in UVA- as compared to UVB-induced skin tumors
in mice (van Kranen et al., 1997), and a second peak of tumor
formation in the UVA range of the squamous cell carcinoma
action spectrum in mice, without a second peak of dimer
formation in that wavelength range (de Gruijl et al., 1993).
However, to our knowledge, epigenetic differences in the
cellular responses to UVA and UVB have as yet not been
discussed to account for the different mutagenic properties of
UVA and UVB.
UVA mutagenesis has been suggested to result from
oxidative DNA base modifications (Darr and Fridovich,
1994; Stary and Sarasin, 2000), such as 7,8-dihydro-8-
oxoguanine (8-oxoG). This mutagenic lesion is a likely
candidate for UVA mutagenesis, as one peak of its formation
has been shown for the UVA range (Kielbassa et al., 1997). If
this is true, one would expect a high proportion of mutations
typically induced by 8-oxoG in the spectrum of UVA-
induced mutations (G-T transversions, generated by mis-
pairing of the template 8-oxoG with adenine, or A-C
transversions, generated by misincorporation of 8-oxoG as
the substrate opposite adenine (Epe, 1991; Cheng et al.,
1992)). Indeed, Besaratinia et al. (2004) found 25% of
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UVA-induced mutations in rodent cells to be G-T transver-
sions, and Persson et al. (2002) found three G-T transver-
sions in the p53 gene of single keratinocytes derived from
UVA-irradiated human skin. Drobetsky et al. (1995) did find a
large proportion of A-C transversions (but not G-T trans-
versions) in the spectrum of UVA-induced mutations in
hamster cells, but not with UVB, and suggested that these
mutations are fingerprints for exposure to UVA. Description
of this mutation in human squamous skin tumors has been
interpreted to indicate a role for UVA in human skin
carcinogenesis (Agar et al., 2004). Other oxidative DNA
lesions or oxygen-radical-induced DNA strand breaks might
also mediate mutation formation following UVA-induced
oxidative stress (Peak et al., 1987; Kuluncsics et al., 1999). If,
for example, thymine glycol, an oxidized pyrimidine lesion,
contributed to UVA mutagenesis, T-C transition mutations
would be expected in the spectrum of UVA-induced
mutations, as thymine glycol has been reported to induce
such lesions (Essigmann et al., 1989). Based on the
assumption that oxidative base damage contributes to solar
mutagenesis, the use of antioxidants in sunscreens has been
widely advertised for the prevention of photocarcinogenesis.
Despite its relatively weak ability to induce pyrimidine
dimers through direct excitation of the DNA molecule, such
lesions have nevertheless been suggested to contribute at
least in part also to UVA mutagenesis. If this is true, C-T
transitions and CC-TT tandem mutations would be ex-
pected in the spectrum of UVA-induced mutations. Recently,
it was suggested that UVA generates CPDs via a photo-
sensitized triplet energy transfer (Douki et al., 2003; Rochette
et al., 2003), in contrast to formation via direct excitation of
DNA by UVB.
Currently available investigations of UVA-induced muta-
tions produced conflicting results and used model systems
that might not reflect well the situation in humans (Drobetsky
et al., 1995; Robert et al., 1996). So far, a detailed spectrum
of UVA-induced mutation in primary human skin cells has
not been available and an understanding of the exact
mechanism of UVA mutagenesis in humans remains elusive
today. In order to study in detail the mechanisms of mutation
formation following UVA exposure, we generated, se-
quenced, and compared mutations in the hypoxanthine-
phosphoribosyl-transferase (hprt) gene generated by exposure
to UVA or UVB in primary human skin fibroblasts.
RESULTS
Mutation formation and cytotoxicity by UVA and UVB
The frequency of spontaneous mutation formation in sham-
irradiated cells was low, with 0.370.6 mutants/one million
colony-forming cells (mean7standard deviation; n¼5).
Increasing mutation frequencies were observed with increas-
ing doses of UVA or UVB (Figure 1). With 200 kJ/m2 UVA, the
induced mutation frequency was 235-fold higher than the
spontaneous mutation rate. Samples that were UVA-irra-
diated through a 320 nm cutoff filter did not exhibit a lower
mutation frequency (n¼ 2), as compared to samples from the
same donor irradiated without the cutoff filter (n¼2). The
frequency of mutations induced by 200 J/m2 UVB was 68-fold
higher than the spontaneous mutation frequency. In these
dose ranges, cells exhibited a similar, mild to moderate
cytotoxicity, as shown in the growth curves (Figure 2).
Comparing roughly equitoxic doses (200 kJ/m2 UVA or 200 J/
m2 UVB), our UVB source yields approximately 300-fold
more mutations per J/m2 than the UVA source. This is well
within the range of published factors or factors calculated
from published data. For human cells, these factors range
from 150 to 1,100 (Wells and Han, 1984; Enninga et al.,
1986; Jones et al., 1987) and for rodent cells from 700 to
50,000 (Drobetsky et al., 1995; Dahle and Kvam, 2003).
Characterization of UVA- and UVB-induced mutants
As the frequency of UV-induced mutations was that much
higher than the background of spontaneous mutation forma-
tion, we are convinced that the vast majority of sequenced
mutants in the UVA- or UVB-irradiated samples were indeed
induced by UV. The hprt-messenger RNA of 55 independent
UVA-induced mutants (derived from 14 independent samples
and cells from 11 different donors) and 58 independent UVB-
induced mutants (derived from 15 independent samples and
cells from nine different donors) was sequenced and the
result confirmed by sequencing in opposite direction. In all,
16% of UVA- and 10% of UVB-induced mutations (differ-
ence not significant) were simple exon deletions, consistent
with mutations at splice-acceptor or splice-donor sites. These
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Figure 1. Dose–response of hprt-mutation formation in UVA- or UVB-
irradiated primary neonatal human fibroblasts. (n¼4–5 for sham-irradiated
samples, and those irradiated with 200 kJ/m2 UVA or 200 J/m2 UVB. n¼ 1 for
all other samples. Error bars show standard deviation).
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Figure 2. Growth curves of primary neonatal human fibroblasts after
irradiation with UVA or UVB. The means7standard deviation of triplicate
samples are shown.
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frequencies are consistent with a published rate of 12.5% of
human hprt mutations, resulting in alterations in RNA
splicing (O’Neill et al., 1998). Figure 3 shows parts of the
hprt-complementary DNA (cDNA) sequence in which we
found mutations and the type of single-base mutations
induced by UVB (shown above the cDNA sequence) and
UVA (shown below the cDNA sequence). Six hotspots for
C:G-T:A transitions and CC:GG-TT:AA tandem mutations
were found, most of which were located within long runs of
pyrimidines (exon 3, positions 145 and 208; exon 5, position
400; exon 6, position 465; exon 8, position 599/600; exon 9,
position 635). Four of these hotspots were identical for UVA
and UVB. One weak hotspot (exon 3, position 146) was only
observed with UVB. At one hotspot with UVA (exon 5,
position 400) only a single mutation event was observed with
UVB. When including the UVA hotspot in exon 5, the
frequency of C:G-T:A transitions in the four/five common
hotspots per mutant is very similar for UVA and UVB (41 and
46%, respectively; difference not significant). In addition,
CC:GG-TT:AA tandem mutations also occurred at these
hotspots, again with both UVB and UVA. Three more
hotspots were observed, two for A:T-G:C transitions in
exon 3 (UVB only) and one for A:T-T:A transversions in
exon 9 (hotspot for UVA, single occurrence with UVB). Single
base-pair insertions (n¼2) and single base-pair deletions
(n¼3) were induced by UVA, but not by UVB.
Figure 4 compares the frequency of each type of single
and tandem base mutations with UVA and UVB. For both
wavelengths, the C:G-T:A transition mutation is by far the
most common type of mutation, at least twice as frequent as
any of the other types of mutations, and their frequency
(including tandem mutations) is not significantly different
between UVA and UVB (46 and 54%, respectively). Except
for the A:T-T:A transversion, which was almost twice as
frequent with UVA than UVB (15 vs 8%; w2¼3.94,
P¼0.047), all other types of single base exchange mutations
showed very similar frequencies in the UVA and UVB
spectrum, or were too rare to allow meaningful comparison.
Overall, there is a marked similarity between the UVA- and
UVB-induced mutation spectra.
p53 activation following exposure to UVA and UVB
Following exposure to the same dose range of UVA and UVB
as used for the mutagenesis studies, primary human neonatal
fibroblasts showed a dose-dependent activation of p53, as
demonstrated by phosphorylation at serine 15 (Figure 5).
However, with UVA, the p53 activation is less pronounced
and more short-lived than with UVB.
DISCUSSION
We describe a detailed spectrum of mutations induced by
UVA and UVB, for the first time in nontransformed, human
Exon 2
Exon 3
Exon 4
Exon 5
Exon 6
Exon 8
Exon 9
Figure 3. Localizations and types of hprt single-base mutations induced by UVB or UVA in primary neonatal human fibroblasts. Parts of the sequence of the
nontranscribed strand in which single-base mutations were found are shown in bold, and UVB-induced mutation above and UVA-induced mutation below the
cDNA sequence. The first base of the start codon is designated as position 1. A double backlash indicates a break in the sequence. Tandem mutations are boxed.
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primary skin cells. The C:G-T:A transition was by far the
most common mutation for both UVA and UVB (41 and 52%
of all mutants, respectively). Such mutations are considered
signature mutations for UV light, as these are only rarely
found after exposure to non-UV carcinogens (Ziegler et al.,
1993; Wikondahl and Brash, 1999). This is even more true for
CC:GG-TT:AA tandem mutations, which we also found
after exposure to UVA and UVB (7 and 4% of all mutations,
respectively). Since pyrimidine dimers (CPDs and (6,4)
pyrimidone photoproducts) are generally accepted to cause
C:G-T:A and CC:GG-TT:AA mutations, our data suggest
that pyrimidine dimers are not only the major contributors to
UVB mutagenesis but also to UVA mutagenesis. This is
further supported by the location of most these mutations
within runs of pyrimidines, as pyrimidine dimer-induced
mutations have been described previously to occur most
commonly in such areas (Brash et al., 1987). In addition, the
fact that most of the hotspots of C:G-T:A transitions were
identical with UVA and UVB also suggests that the UVA- and
UVB-induced C:G-T:A transitions were formed through the
same mechanisms, namely pyrimidine dimers. It remains
unclear if smaller differences reflect experimental variability
or mechanistic differences in mutation formation.
Dimer-induced C:G-T:A transitions have been described
to be more common on the nontranscribed strand, presum-
ably due to faster repair of dimers on the transcribed strand
(McGregor et al., 1991). After irradiation of cells in G1 phase,
80% of UV-induced C:G-T:A transitions were reported to
be located on the nontranscribed strand of hprt of human
fibroblasts. This is consistent with our data which show most
of the C:G-T:A transitions also located on the nontran-
scribed strand (85% for UVA; 78% for UVB), including four
of the five C:G-T:A hotspots. This further substantiates the
interpretation that our C:G-T:A transitions have indeed
been generated by pyrimidine dimers.
The possibility that an undetected contamination of our
UVA source with UVB could have been responsible for dimer
formation and subsequent C:G-T:A transition formation was
excluded by showing that the use of a 320 nm cutoff filter did
not reduce the frequency of UVA mutations.
Although the ability of UV light to induce DNA photo-
products decreases exponentially with increasing wave-
lengths, UVA is still able to generate such damage, in vitro
and in vivo (Freeman et al., 1987; Matsunaga et al., 1991;
Kielbassa et al., 1997; Ley and Fourtanier, 2000). Douki et al.
(2003) reported that single-strand breaks, oxidized pyri-
midines, oxidized purines (mainly 8-oxoG), and CPDs are
formed in a 1:1:3:10 ratio with UVA, using a very similar
UVA source as we did in this study. Considering that we have
used a 1,000-fold higher dose of UVA than UVB, it may not
be surprising to find pyrimidine dimer-induced C:G-T:A
transitions after exposure to UVA. Douki et al. (2003) also
reported the distribution of bipyrimidine photoproducts at the
four possible dipyrimidine sites (TT, CC, TC, and CT) within
the DNA of Chinese hamster ovary (CHO) cells after
irradiation with UVA or UVB. While the TT-CPD was the
most common type for both wavelengths, UVB induced
several other types with almost the same frequency, while
many types were not detected after UVA (most notably (6–4)
adducts and CC-CPDs), and TC- and CT-CPDs were detected
only with a much lower frequency than TT-CPDs. As similar
results were recently reported for UVA and primary human
keratinocytes and fibroblasts (Courdavault et al., 2004), our
data suggest, consistent with published data (sometimes
referred to as the A-rule; Strauss, 1991), that TT-CPDs are not
very mutagenic, and that CPDs at cytosine-dipyrimidine sites
contribute most to UVA and UVB mutagenesis, despite their
less frequent, and in the case of UVA, much less frequent
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670 Journal of Investigative Dermatology (2006), Volume 126
UP Kappes et al.
UVA- and UVB-Induced Mutations in Human Skin Cells
formation. This has been suggested to be due to the mutation-
prevention effects of DNA polymerase Z or other translesional
DNA polymerases (Taylor, 2002; Choi and Pfeifer, 2005;
Lehmann, 2005). Our data, showing that most of our UVA-
induced C:G-T:A transitions are located at CT sites, and less
at TT sites is consistent with this explanation. A notable
exception is the hotspot in exon 3, which is located within a
run of cytosines, presumably caused by a CC dimer, a type
that was not found after UVA exposure by Douki et al. (2003)
and Courdavault et al. (2004).
Unlike UVC, which is considered to induce mostly, if not
exclusively, pyrimidine dimer-type DNA damage, both UVB
and UVA have been reported to generate a variety of different
types of DNA damage besides pyrimidine dimers, including
various types of oxidative DNA damage, DNA strand breaks
or other ‘‘minor’’ photoproducts (Peak and Peak, 1990;
Kielbassa et al., 1997). It is therefore difficult to extrapolate
from a given mutation to the inducing DNA lesion. For
example, the A:T-G:C can be generated at a pyrimidine
dimer, or at the oxidative thymine base modification thymine
glycol (Basu et al., 1989). In our mutation spectra, all of these
mutations were found to be located at possible pyrimidine
dimer sites. They do not, however, show the bias for the
nontranscribed strand, as seen for the C:G-T:A transitions.
Two hotspots for the formation of A:T-G:C mutations were
observed with UVB on exon 3, but none with UVA. While the
overall frequency of this type of mutation was not signifi-
cantly different between UVA and UVB (13 and 17%,
respectively), the difference in hotspot formation might
indicate that UVA and UVB generate them through a different
mechanism. Similarly, the difference in the frequencies and
hotspot formation with the A:T-T:A mutation might also
point to differences in mutation formation. However, as the
frequencies of these two types of mutations are low overall,
these differences can only be considered minor. The G:C-
T:A and G:C-C:G transversions have been described to be
typical mutations at sites of 8-oxoG, and A:T-C:G trans-
versions to be caused by misincorporation of 8-oxoG as the
substrate opposite of adenine (Epe, 1991; Cheng et al., 1992).
In our data, such mutations occurred at similar frequencies
after irradiation with UVA (13%) and UVB (15%). This is
consistent with both UVA and UVB being able to induce 8-
oxoG (Kielbassa et al., 1997). The fact that two UVB-induced
G:C-T:A transversions occurred at the same site as the
hotspot for G:C to A:T transitions in exon 3 (Figure 3) might
indicate that even this type of mutation was not formed by an
oxidized guanine, but at a pyrimidine dimer on the other
strand. This possibility is supported by the description of
G:C-T:A transversions with UVC (254 nm), a wavelength
considered to generate almost exclusively pyrimidine dimers
(McGregor et al., 1991). Even if all transversions were
induced by 8-oxoG, our data clearly indicate that, in
comparison to pyrimidine dimers, 8-oxoG could only be a
minor contributor to either UVA or UVB mutagenesis. As a
practical consequence, the current advocating of antioxidants
for skin cancer protection might need to be questioned. The
recently reported somewhat higher frequency of G:C-T:A
transversions (25%) with UVA in rodent cells (Besaratinia
et al., 2004) might be attributable to the difference between
rodent and human cells. A rate of this type of mutations with
UVB was not reported in that study.
Single-base insertions and single-base deletions require
formation of a single- or double-strand break, either as initial
lesion, or as a repair intermediate. As such mutations were
only found with UVA, but not with UVB, this might point to a
contribution, albeit a small one, of DNA strand breaks to
UVA mutagenesis in particular. UV-induced 1 frameshift
mutations have also been described following dimerization of
nonadjacent pyrimidines with a single intervening nucleotide
(Nguyen and Minton, 1988; Lingbeck and Taylor, 1999).
However, at the site of our 1 deletion, such dimers could
not be formed, because the deleted base is flanked by one
pyrimidine and one purine.
Drobetsky et al. (1995) sequenced UVA- and UVB-
induced mutations using an immortalized strain of CHO
cells. With UVB, they also found predominantly C:G-T:A
transitions, but the spectrum of the less common mutations
differs considerably from ours. In contrast to our data with a
marked similarity between the UVB- and the UVA-induced
mutation spectra, they found large differences between UVB
and UVA, with a lower frequency of C:G-T:A transitions
(albeit the same frequency of CC:GG-TT:AA tandem
mutations), and a much higher frequency of A:T-C:G
transversions with UVA. The latter was suggested to
constitute a molecular fingerprint for mutations induced by
UVA in rodent cells and for that reason has been used to
attribute mutations found in human cutaneous squamous cell
carcinomas and actinic keratoses to UVA (Agar et al., 2004).
Our data do not confirm this UVA fingerprint mutation for
human cells. While Drobetsky et al. (1995) acknowledge a
possible contribution of pyrimidine dimers to UVA mutagen-
esis, our data point to a much more prominent role of these
lesions in UVA mutagenesis. The type of cells used might
explain these differences: While we used primary human skin
cells, they studied CHO cells. These cells, as rodent cells in
general, are well known to be relatively deficient in
nucleotide excision repair, as compared to human cells
(Hanawalt, 2001). In addition, immortalization is known to
often alter the way how cells respond to DNA damage. For
example, p53, a pivotal, UV-activated regulator of apoptosis,
cell cycle, and DNA repair, is commonly inactivated in
immortalized cells (Finlay, 1992; Tiemann and Deppert,
1994). As the spontaneous mutation frequency with these
cells was high, irradiation with high doses of UVA for 2 hours
was needed to observe a UVA-induced mutation frequency
three- to five-fold above the spontaneous background. This
means that 20–33% of the mutations observed after UVA
irradiation were actually not UVA-induced, but represent
spontaneous mutations. In our experiments, the frequency of
UVA-induced mutations was 68- to 235-fold higher than the
spontaneous background, indicating that only 0.4–1.5% of
our mutations observed after UVA irradiation represent
spontaneous mutations. Finally, differences might also be
attributable to the different emission spectra of UVA lamps
used and the much weaker output of their fluorescent UVA
lamp, which required irradiation for 2 hours, while our
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stronger UVA emitter required irradiation times of only less
than 15 minutes.
Robert et al. (1996) studied UVA- and UVB-induced
mutations in adenovirus-transformed human embryonic
kidney cells, stably transfected with an extrachromosomal
shuttle vector harboring the lacZ bacterial gene as mutagen-
esis target. Consistent with our data, they also found a
majority of point mutations to be C:G-T:A transitions with
both UVB and UVA (68% out of 34 point mutations and 54%
out of 22 point mutations, respectively). The spectra of the
remaining mutations were also similar to our results. While
almost all mutations were located at dipyrimidine sites, the
distribution of UV-induced mutations in the mutagenesis
target gene was significantly different for UVB and UVA. This
is in contrast to our data, where we found the same hotspots
for C:G-T:A transitions with UVA and UVB. These
differences might again be attributable to the different model
systems (their extra-chromosomal, plasmid-encoded bacterial
gene versus our human chromosomal gene; their transformed
kidney cell line versus our primary skin cells).
Rochette et al. (2003) quantified CPD formation at
nucleotide resolution along one exon of hprt in CHO cells
following exposure to UVA, UVB, UVC, and solar simulated
light, and aligned the resulting DNA damage spectrum with
the corresponding mutational spectrum previously reported,
as mentioned above, by Drobetsky et al. (1995). In contrast to
UVC, UVB, and solar simulated light, where CPD damage
hotspots corresponded to C:G-T:A mutation hotspots, UVA
generated CPDs more frequently at TT sites, correlating well
with the high proportion of mutations recovered opposite of
TT dipyrimidines in UVA-irradiated CHO cells. They
conclude that UVA-induced CPDs are formed through means
other than (or in addition to) direct absorption by DNA, and
suggest triplet photosensitization to be responsible for these
UVA-induced CPDs at TT sites. While their conclusion that
CPDs are a major promutagenic DNA photoproduct in UVA
mutagenesis is consistent with our data, we did not find any
indications that UVA-induced mutations are generated at
CPDs formed through a mechanism different from those
responsible for UVB-induced mutations, as the mutation
spectra, including hotspots, were very similar for UVA and
UVB, and no particular predominance of mutations at TT
sites was noted. These differences might again be due to the
different UVA sources, cell types, and experimental designs
used by Drobetsky et al. (1995), as discussed above, as the
conclusions of Rochette et al. (2003) are based on the
mutation spectra from Drobetsky et al. (1995). In addition,
their findings might have been, at least in part, influenced by
the unphysiologically high doses of UVA, as they used up to
more than 20-fold higher UVA doses than we did in our
mutagenesis studies. Alternatively, dimers might be formed
preferentially at TT sites, but not contribute to mutation
formation in human cells, as discussed above.
Pyrimidine dimer-induced C:G-T:A and CC:GG-TT:AA
mutations are regarded as UV-signature mutations. Here we pro-
vide strong evidence that these mutations are signatures not only
for an exposure to UVB but also to UVA. Our results with
the striking similarity between the UVA- and UVB-induced
mutation spectra do not support a major role or an increasing
role of non-dimer DNA damage with increasing wavelength.
The findings of increasing mutagenicity per dimer with
increasing wavelength (Enninga et al., 1986) and the second
peak in the UVA range of the carcinogenesis action spectrum
without a second peak of dimer formation within that range
of wavelengths (de Gruijl et al., 1993) might therefore need to
be explained by epigenetic differences in the cellular
responses to UVB and UVA. We would like to speculate
that a less protective cellular DNA damage response to UVA,
as compared to UVB, could reconcile our data with
previously published ones. Just as one example of a
profoundly different DNA damage response, we would like
to suggest that the less prominent and less long-lasting
activation of p53 after exposure to UVA (Figure 5) might be
contributing to the different mutagenic outcomes of UVB- or
UVA-induced pyrimidine dimers. While the strong activation
of p53 after UVB assures its function as ‘‘guardian of the
genome’’, the weaker activation of p53 after UVA increases
the chance that a pyrimidine dimer leads to mutation
formation, due to less cell cycle arrest and a subsequent
higher chance of replication of a damaged template, and due
to less p53-mediated induction of DNA repair. Due to less
p53-mediated apoptosis, it might also entail a higher chance
that a cell with DNA damage or mutations will survive, and
potentially go on to form skin cancer. If this speculation is
true, that an UVA-induced dimer is more mutagenic due to a
less pronounced protective DNA damage response, one
would have to conclude that exposure to a given UVA dose
from a pure UVA source, such as those often used in tanning
parlors or in medical devices for high-dose UVA1 therapy,
might be more harmful than receiving the same UVA dose
from a mixed UVA–UVB source, such as natural sunlight, as
the UVB will induce a better protective cellular response and
reduce the mutability of UVA-induced DNA damage. More
work is required to confirm the impact of different DNA
damage responses to UVA and UVB and of interactions
between UVA and UVB on mutagenic outcomes.
MATERIALS AND METHODS
Cell lines and culture conditions
Primary human fibroblasts were derived from dermal explants of the
neonatal foreskin without identifiable patient data as described
previously (Stanulis-Praeger and Gilchrest, 1989) and cultured in
Dulbecco’s modified Eagle’s medium (Gibco/BRL, Rockland, MA)
supplemented with 10% calf serum at 371C and 5% CO2. Only low
passage number cells (maximum passage 3) were used. Cells from a
different donor were used for each experiment. Limiting the source
to neonatal cells excludes the possibility of variability due to donor
age and age-dependent decline in DNA repair capacity. All
experiments were performed with institutional approval.
HPRT-mutagenesis assay
The HPRT-mutagenesis assay was used as described previously to
detect and characterize UV-induced hprt mutations (McCormick and
Maher, 1988; Zdzienicka, 1999). Exponentially growing cells were
irradiated with UVA, UVB, or sham (see below) at approximately
40% confluence. After irradiation, cells were propagated for 3.5–4
672 Journal of Investigative Dermatology (2006), Volume 126
UP Kappes et al.
UVA- and UVB-Induced Mutations in Human Skin Cells
population doublings (expression period), as verified by cell counts
in parallel dishes, to allow for expression of mutated hprt. After 5–12
days, cells were transferred into 10–20 tissue culture dishes, at a
density of 5,100 cells/cm2, with a selective medium containing 7mg/
ml 6-thioguanine (Sigma, St. Louis, MO). In this selective medium,
only cells with HPRT-inactivating mutations can grow and form
colonies, as they do not metabolize 6-thioguanine to a toxic agent.
After a selection period of 4–6 weeks, hprt-mutant, 6-thioguanine-
resistant cell colonies were either stained with 0.2% methylene blue
and counted for mutation frequency, or harvested for hprt sequen-
cing. The mutation frequency was calculated as the number of
mutants/number of plated cells plating efficiency. The latter was
determined by plating 100 cells/dish separately in nonselective
medium at the end of the expression period. The mean plating
efficiency was 5078%.
UV-irradiation protocol
After washing twice with phosphate-buffered saline, cells were
irradiated with a thin cover of phosphate-buffered saline (2 ml in
p100 dishes) to avoid drying, and on a water bath at room
temperature to avoid overheating during irradiation. Irradiation
was performed through the lid of the tissue culture dish (Falcon,
Becton Dickinson, Franklin Lakes, NJ) to ensure sterility of the long-
term cultures.
For UVA1 irradiation (with only small amounts of contaminating
UVA2 and no detectable UVB with a minimum detection sensitivity
of 1 106 W/cm2), we used a 2 kW metal halogenide UVA lamp
(SELLAS Sunlight, Germany) with an emission spectrum ranging from
335 to 440 nm and an emission maximum at 375 nm (Figure 6). In
all, 99.954% of the emitted UVA is UVA1 (340–400 nm). The
spectral irradiance of the lamp was measured with a doublemono-
chromator spectroradiometer Bentham DM150 (Bentham Instru-
ments Ltd, Reading, UK), which is designed for optimized dynamic
range and straylight reduction in the UV wavelength range. The
detector was a photomultiplier tube, the input optics consisted of a
2.5-cm-diameter teflon diffusor with cosine response characteristic.
The calibration was performed with a quarz tungsten halogen cali-
bration lamp traceable to Physikalisch Technische Bundesanstalt.
The stepwidth and bandwidth was 1 nm.
After warm-up, an irradiance value (not spectrally weighted) of
approximately 30 mW/cm2 at 35 cm distance allowed irradiation
with, for example, 200 kJ/m2 in less than 12 minutes. The lamp also
contained an infrared filter that prevented excessive warming of
irradiated samples. For most experiments, we used a UVA dose of
200 kJ/m2. This is a relevant and solar available dose, since it can be
acquired during about 1 hour summer sun exposure at noon time
(Jeanmougin and Civatte, 1987). Tanning beds use even higher
doses, up to 600 kJ/m2. For one experiment, two tissue culture dishes
were irradiated with 200 kJ/m2 through a 320 nm cutoff filter (1 mm;
Schott, Duryea, PA), parallel to two samples irradiated with the same
dose without this filter. Irradiation time was adjusted for equal
dosing and was 14.7% higher for the samples irradiated through the
filter.
A solar simulator (LH 153, Kratos Analytical, Ramsey, NJ) was
used to expose cells to broad-spectrum UVB. The tissue culture lid
also removes contaminating UVC and only slightly reduces
irradiance of the shorter wavelengths of the UVB range. The
resulting emission spectrum was published by Werninghaus et al.
(1991). After warm-up, an irradiance level of approximately
0.06 mW/cm2 allowed irradiation with, for example, 200 J/m2 UVB
in less than 6 minutes. The UVA emitted by this source at the
maximum UVB doses used was less than 2.5 kJ/m2, consistent with
previous reports that solar simulators often emit insufficient long-
wave UVA to adequately simulate natural sunlight (Sayre et al.,
1990; Stary and Sarasin, 2000). This low UVA dose did not affect cell
survival or proliferation. With a four-fold higher dose of UVA (10 kJ/
m2), we did not detect any mutation formation above background
(Figure 1), indicating that the UVA contained in the solar simulator
did not contribute to mutation formation. For most experiments, we
used a UVB dose of 200 J/m2, also a solar available dose, and easily
accumulated during 10–15 minutes of midsummer mid-day sun
exposure.
Radiometric measurements were performed for each experiment.
For dosimetry, an IL-1700 Research Radiometer (International Light,
Newburyport, MA) was used, equipped with a UVA sensor (SEF 015)
or a UVB sensor (SED 240).
Immediately after irradiation, the phosphate-buffered saline
cover was removed, and cells were fed with fresh prewarmed
complete medium.
Sequencing of hprt-mutant cells
HPRT-cDNA was amplified after isolation of messenger RNA from
single mutant colonies by nested RT-PCR using two published primer
pairs (Yang et al., 1989) and a high-fidelity Taq polymerase
(Invitrogen, Carlsbad, CA). HPRT was sequenced using automated
DNA sequencing, using PCR primers, and aligned with the published
human hprt sequence (Jolly et al., 1983) using Jellyfish software
(Version 3.0, LabVelocity, Los Angeles, CA). All mutations found
were confirmed by sequencing in reverse direction. Identical
mutations were only counted if the mutant colonies were derived
from separate dishes. While this might underestimate mutation
hotspots, it ensures that mutant colonies derived from the same
mutation event are not counted more than once. The w2 test was used
to compare counts of different types of UVA- and UVB-induced
mutations.
Immunoblotting
At 2 days after plating, subconfluent, exponentially growing cultures
of primary neonatal fibroblasts from one donor were irradiated with
various doses of UVA or UVB as described above in p60 tissue
culture dishes. At 2, 6, 12, or 24 hours after irradiation, whole-cell
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extracts were prepared and Western blotting was carried out using
standard procedures with 20mg of protein. UVA- and UVB-irradiated
samples were run in parallel on two gels (10% acrylamide) in the
same electrophoresis apparatus at the same time. The primary
antibodies utilized were directed against serine-15 phosphorylated
p53 (Cell Signaling, Beverly, MA) and actin (I-19) horseradish
peroxidase conjugate (Santa Cruz, Santa Cruz, CA). The secondary
antibody for the detection of serine-15 phosphorylated p53 was
enhanced chemiluminescent-anti-rabbit peroxidase-linked species-
specific antibody from donkey (Amersham Biosciences, Piscataway,
NJ). Autoradiography of the two membranes was performed
simultaneously onto a single sheet of film. Densitometry of the
single autoradiogram (with both the UVA- and the UVB-irradiated
samples) was performed using Quantity One software (Bio-Rad,
Hercules, CA).
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported by a grant from the American Cancer Society to
T.M.R. and by a grant from the Deutsche Forschungsgemeinschaft to U.P.K.
We thank Jessica Dunn for technical assistance.
REFERENCES
Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones
AM (2004) The basal layer in human squamous tumors harbors more
UVA than UVB fingerprint mutations: a role for UVA in human skin
carcinogenesis. Proc Natl Acad Sci USA 101:4954–9
Basu AK, Loechler EL, Leadon SA, Essigmann JM (1989) Genetic effects of
thymine glycol: site-specific mutagenesis and molecular modeling
studies. Proc Natl Acad Sci USA 86:7677–81
Besaratinia A, Synold TW, Xi B, Pfeifer GP (2004) G-to-T transversions and
small tandem base deletions are the hallmark of mutations induced by
ultra-violet A radiation in mammalian cells. Biochemistry 43:8169–77
Brash DE, Seetharam S, Kraemer K, Seidman MM, Bredberg A (1987)
Photoproduct frequency is not the major determinant of UV base
substitution hot spots or cold spots in human cells. Proc Natl Acad Sci
USA 8:3782–6
Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA (1992) 8-Hydro-
xyguanine, an abundant form of oxidative DNA damage, causes G to T
and A to C substitutions. J Biol Chem 267:166–72
Choi JH, Pfeifer GP (2005) The role of DNA polymerase eta in UV mutational
spectra. DNA Repair 4:211–20
Courdavault S, Baudouin C, Charveron M, Favier A, Cadet J, Douki T (2004)
Larger yield of cyclobutane dimers than 8-oxo-7,8-dihydroguanine in the
DNA of UVA-irradiated human skin cells. Mutat Res 556:135–42
Dahle J, Kvam E (2003) Induction of delayed mutations and chromosomal
instability in fibroblasts after UVA-, UVB-, and X-radiation. Cancer Res
63:1464–9
Darr D, Fridovich I (1994) Free radicals in cutaneous biology. J Invest
Dermatol 102:671–5
De Fabo EC, Noonan FP, Fears T, Merlino G (2004) Ultraviolet B but not
ultraviolet A radiation initiates melanoma. Cancer Res 64:6372–6
de Gruijl FR, Stern MH, Forbes PD (1993) Wavelength dependence of skin
cancer induction by ultraviolet irradiation of albino hairless mice.
Cancer Res 53:53–60
Douki T, Perdiz D, Grof P, Kuluncsics Z, Moustacchi E, Cadet J et al. (1999)
Oxidation of guanine in cellular DNA by solar UV radiation: biological
role. Photochem Photobiol 70:184–90
Douki T, Reynaud-Angelin A, Cadet J, Sage E (2003) Bipyrimidine
photoproducts rather than oxidative lesions are the main type of DNA
damage involved in the genotoxic effect of solar UVA radiation.
Biochem 42:9221–6
Drobetsky EA, Turcotte J, Chateauneuf A (1995) A role for ultraviolet A in
solar mutagenesis. Proc Natl Acad Sci USA 92:2350–4
Enninga IC, Groenendijk RTL, Filon AR, van Zeeland AA, Simons JWIM
(1986) The wavelength dependence of u.v.-induced pyrimidine dimer
formation, cell killing and mutation induction in human diploid skin
fibroblasts. Carcinogenesis 7:1829–36
Epe B (1991) Genotoxicity of singlet oxygen. Chem Biol Interact 80:239–60
Essigmann JM, Basu AK, Loechler EL (1989) Mutagenic specificity of alkylated
and oxidized DNA bases as determined by site-specific mutagenesis.
Ann Inst Sup San 25:155–61
Finlay CA (1992) p53 loss of function: implications for the processes of
immortalization and tumorigenesis. BioEssays 14:557–60
Freeman SE, Gange RW, Sutherland JC, Matzinger EA, Sutherland BM (1987)
Production of pyrimidine dimers in DNA of human skin exposed in situ
to UVA radiation. J Invest Dermatol 88:430–3
Hanawalt PC (2001) Revisiting the rodent repairadox. Env Mol Mutagen
38:89–96
Jeanmougin M, Civatte J (1987) Dosime´trie du rayonnement ultraviolet
solaire. Variations journalie`res et mensuelles a` Paris. Ann Dermatol
Venereol 114:671–6
Jolly DJ, Okayama H, Berg P et al. (1983) Isolation and characterization of a
full-length expressible cDNA for human hypoxanthine phosphoribosyl-
transferase. Proc Natl Acad Sci USA 80:477–81
Jones CA, Huberman E, Cunningham ML, Peak MJ (1987) Mutagenesis and
cytotoxicity in human epithelial cells by far- and near-ultraviolet
radiations: action spectra. Radiat Res 110:244–54
Kielbassa C, Roza L, Epe B (1997) Wavelength dependence of oxidative DNA
damage induced by UV and visible light. Carcinogenesis 18:811–6
Kuluncsics Z, Perdiz D, Brulay E, Muel B, Sage E (1999) Wavelength
dependence of ultraviolet-induced DNA damage distribution: involve-
ment of direct or indirect mechanisms and possible artefacts.
J Photochem Photobiol B 49:71–80
Lehmann AR (2005) Replication of damaged DNA by translesion synthesis in
human cells. FEBS Lett 579:873–6
Ley RD, Fourtanier A (2000) UVA1-induced edema and pyrimidine dimers in
murine skin. Photochem Photobiol 72:485–7
Lingbeck JM, Taylor JS (1999) Preparation and characterization of DNA
containing a site-specific nonadjacent cyclobutane thymine dimer of the
type implicated in UV-induced-1 frameshift mutagenesis. Biochemistry
38:13717–24
Matsunaga T, Hieda K, Nikaido O (1991) Wavelength dependent formation of
thymine dimers and (6–4) photoproducts in DNA by monochromatic
ultraviolet light ranging from 150 to 365 nm. Photochem Photobiol
54:403–10
McCormick JJ, Maher VM (1988) Measurement of colony-forming ability and
mutagenesis in diploid human cells. In: DNA repair: a laboratory manual
of research procedures. (Friedberg EC, Hanawalt PC, eds), New York:
Marcel-Dekker, 501
McGregor WG, Chen RH, Lukash L, Maher VM, McCormick JJ (1991) Cell
cycle-dependent strand bias for UV-induced mutations in the transcribed
strand of excision repair-proficient human fibroblasts but not in repair-
deficient cells. Mol Cell Biol 11:1927–34
Moan J, Dahlbeck A, Setlow RB (1999) Epidemiological support for an
hypothesis for melanoma induction indicating a role for UVA radiation.
Photochem Photobiol 70:243–7
Nguyen HT, Minton KW (1988) Ultraviolet-induced dimerization of non-
adjacent pyrimidines. A potential mechanism for the targeted-1 frame-
shift mutation. J Mol Biol 200:681–93
O’Neill JP, Rogan PK, Cariello N, Nicklas JA (1998) Mutations that alter RNA
splicing of the human HPRT gene: a review of the spectrum. Mutat Res
411:179–214
Peak JG, Peak MJ (1990) Ultraviolet light induces double-strand breaks in
DNA of cultured human P3 cells as measured by neutral filter elution.
Photochem Photobiol 52:387–93
674 Journal of Investigative Dermatology (2006), Volume 126
UP Kappes et al.
UVA- and UVB-Induced Mutations in Human Skin Cells
Peak MJ, Peak JG, Carnes BA (1987) Induction of direct and indirect single-
strand breaks in human cell DNA by far- and near-ultraviolet radiations:
action spectrum and mechanisms. Photochem Photobiol 45:381–7
Persson AE, Edstrom DW, Backvall H, Lundeberg J, Ponten F, Ros AM et al.
(2002) The mutagenic effect of ultraviolet-A1 on human skin demon-
strated by sequencing the p53 gene in single keratinocytes. Photo-
dermatol Photoimmunol Photomed 18:287–93
Robert C, Mueller H, Benoit A, Dubertret L, Sarasin A, Stary A (1996) Cell
survival and shuttle vector mutagenesis induced by ultraviolet A and
ultraviolet B radiation in a human cell line. J Invest Dermatol 106:721–8
Rochette PJ, Therrien JP, Drouin R, Perdiz D, Bastien N, Drobetsky EA et al.
(2003) UVA-induced cyclobutane pyrimidine dimers form predomi-
nantly at thymine–thymine dipyrimidines and correlate with the mutation
spectrum in rodent cells. Nucleic Acids Res 31:2786–94
Ru¨nger TM (1999) The role of UVA in the pathogenesis of melanoma and
non-melanoma skin cancer. Photodermatol Photoimmunol Photomed
15:212–6
Sayre RM, Cole C, Billhimer W, Stanfield J, Ley RD (1990) Spectral
comparison of solar simulators and sunlight. Photodermatol Photo-
immunol Photomed 7:159–65
Stanulis-Praeger BM, Gilchrest BA (1989) Effect of donor age and prior sun
exposure on growth inhibition of cultured human dermal fibroblasts by
all trans-retinoic acid. J Cell Physiol 139:116–24
Stary A, Sarasin A (2000) Ultraviolet A- and singlet oxygen-induced mutation
spectra. Methods Enzymol 319:153–65
Strauss BS (1991) The ‘A’ rule of mutagen specificity: a consequence of DNA
polymerase bypass of non-instructional lesions? BioEssays 13:1–6
Taylor JS (2002) New structural and mechanistic insight into the A-rule and
the instructional and non-instructional behavior of DNA photoproducts
and other lesions. Mutat Res 510:55–70
Tiemann F, Deppert W (1994) Stabilization of the tumor suppressor
p53 during cellular transformation by simian virus 40: influence of
viral and cellular factors and biological consequences. J Virol 68:
2869–78
van Kranen HJ, de Laat A, van de Ven J et al. (1997) Low incidence of p53
mutations in UVA (365-nm)-induced skin tumors in hairless mice.
Cancer Res 57:1238–40
Wang SW, Setlow RB, Berwick M, Polsky D, Marghoob AA, Knopf AW et al.
(2001) Ultraviolet A and melanoma: a review. J Am Acad Dermatol
44:837–46
Wells RL, Han A (1984) Action spectra for killing and mutation of Chinese
hamster cells exposed to mid- and near-ultraviolet monochromatic light.
Mutat Res 129:251–8
Werninghaus K, Handjani RM, Gilchrest BA (1991) Protective effect of alpha-
tocopherol in carrier liposomes on ultraviolet-mediated human epider-
mal cell damage in vitro. Photodermatol Photoimmunol Photomed
8:236–42
Wikondahl NM, Brash DE (1999) Ultraviolet radiation induced
signature mutations in photocarcinogenesis. J Investig Dermatol Symp
Proc 4:6–10
Yang JL, Maher VM, McCormick JJ (1989) Amplification and direct nucleotide
sequencing of cDNA from the lysate of low numbers of diploid cells.
Gene 83:347–54
Zdzienicka MZ (1999) Isolation of mutagen-sensitive Chinese hamster cell
lines by replica plating. In: Methods in molecular biology, vol. 113:
DNA repair protocols. Eukaryotic systems. (Hendersen DE, ed), Totowa,
NJ: Humana Press, 49
Ziegler A, Leffell DJ, Kunala S et al. (1993) Mutation hotspots due to sunlight
in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA
90:4216–20
www.jidonline.org 675
UP Kappes et al.
UVA- and UVB-Induced Mutations in Human Skin Cells
